BLEEDING
Clinical trials for BLEEDING explained in plain language.
Never miss a new study
Get alerted when new BLEEDING trials appear
Sign up with your email to follow new studies for BLEEDING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Aspirin study for kidney patients halted early – did the risks outweigh the benefits?
Disease control TerminatedThis study looked at whether taking a daily low-dose aspirin could help people with chronic kidney disease avoid their first heart attack or stroke. Over 4,600 participants were randomly assigned to take aspirin or receive usual care. The trial was stopped early, and the final re…
Matched conditions: BLEEDING
Phase: PHASE3 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Bleeding breakthrough fizzles: fibrinogen trial for chemo patients halted after just one patient
Disease control TerminatedThis study tested a single injection of fibrinogen concentrate followed by a platelet transfusion in blood cancer patients with severe bleeding who did not respond to standard platelet transfusions. The goal was to see if it improved blood clotting. However, the trial was termina…
Matched conditions: BLEEDING
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC